Open Access

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Interactions and management

Event: ESC Preventive Cardiology 2022
Topic: Lipids
Session type: Symposium
Date: 9 April 2022
Time: 09:25 - 10:10

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

What is NAFLD/NASH? .

Speaker: Doctor H. Cortez-Pinto (Lisbon, PT)
Thumbnail

NAFLD/NASH and the heart.

Speaker: Doctor M. Tushuizen (Leiden, NL)
Thumbnail

Managing patients with cardiovascular disease and NAFLD/NASH.

Speaker: Professor S. Francque (Antwerpen, BE)
Thumbnail

Discussion : Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Interactions and management.

Thumbnail

3 speakers from this session

Doctor Helena Cortez-Pinto

Faculty of Medicine University of Lisbon, Lisbon (Portugal)
1 presentation
0 follower

Doctor Maarten Tushuizen

Leiden University Medical Center, Leiden (Netherlands (The))
1 presentation
0 follower

Professor Sven Francque

University Hospital Antwerp, Antwerpen (Belgium)
1 presentation
0 follower

Related content

ESC Premium Access

Trials Focus: GUIDE-HF / EMPEROR-Preserved

3 December 2021

ESC Premium Access

Management of diabetes mellitus in patients with cardiovascular disease

3 December 2021

ESC Premium Access

Pregnancy in women with cardiovascular disease

3 December 2021

This platform is supported by

logo Novo Nordisk